Skip to main content
. 2023 Jul 18;101(3):e238–e252. doi: 10.1212/WNL.0000000000207402

Figure 1. Participant Disposition.

Figure 1

Two hundred ninety-six participants were screened, and 218 participants were randomized to treatment. Two participants in the elamipretide group and 1 patient in the placebo group had the treatment withdrawn due to adverse event before study discontinuation. The ITT population included 109 participants in the elamipretide group and 109 participants in the placebo group. The PP population included 102 participants in the elamipretide group and 103 participants in the placebo group. ITT = intention-to-treat; PP = per-protocol.